7. Cervical screening programme update
• HPV Primary Screening Implementation
• 14 Day Turnaround Times
• Clinical Professional Groups
• Research and Advisory Groups
• Primary Care Support England PCSE
• Updated Programme guidance
• Coverage
• Blogs and Communications
7 Cervical Screening Programme Update 12 10 2017 E-learning Launch
8. Key benefits of primary HPV screening
• Primary HR-HPV testing has higher sensitivity for high
grade cervical intraepithelial neoplasia (CIN) than
primary cytology. Using primary HR-HPV testing to
screen women will identify more women at risk of
developing cervical cancer.
• HR-HPV testing has a lower false negative rate than
cytology. Meaning we will have the potential to increase
screening intervals in the future for HR-HPV negative
women.
• UKNSC recommendation 2016
• Implementation by 2019
Cervical Screening Programme Update 12 10 2017 E-learning Launch8 Cervical Screening Programme Update 12 10 2017 E-learning Launch
9. Primary HR-HPV testing pathway
Impacts upon all programme elements
• Call and recall and IT
• Information for women
• Sample takers
• Screening laboratories
• Screening protocol algorithm
• Colposcopy service and management of women
• Histology
Cervical Screening Programme Update 12 10 2017 E-learning Launch9 Cervical Screening Programme Update 12 10 2017 E-learning Launch
13. 13 Cervical screening coverage data project
14 dayTAT
performance
September2017
Source: Exeter
VSA15 report for
September 2017
Showing proportion
of women in each
CCG receiving their
cervical screening
result within 14 days
of date test taken.
14. 14 day turnaround times for samples
14 Cervical Screening Programme Update 12 10 2017 E-learning Launch
• Laboratories continue with workforce capacity issues
and unable to achieve national target of women
receiving their results within 14 days.
• Mitigations are in place to start to address to extend
HPV primary screening in pilot sites
• Further Quality Review meetings have been held to
consider further options with NHS England and PHE
15. Clinical Professional Groups
Key Role in: Reviewing and producing guidance
Advisory role to the programme
Developing standards
• Colposcopy Clinical Professional Group
Reviewing the NHS CSP Colposcopy programme management guidelines
Working with the programme to develop standards
• Laboratory Clinical Professional Group
Reviewing the NHS CSP laboratory programme management guidelines
Developing Histology , failsafe, HBPC guidance
• Cervical Screening Education and Training Clinical Professional Group
Developing guidance for Training and Education both in Cytology and Sample taking.
15 Cervical Screening Programme Update 12 10 2017 E-learning Launch
16. Development of Programme Specific
Standards
16 Cervical Screening Programme Update 12 10 2017 E-learning Launch
• The standards provide a defined set of measures that providers have to
meet to ensure local programmes are safe and effective.
• Consolidated standards focus on standards for improving the quality of
screening programmes.
• Additional operational guidance is included our guidance documents
• Service specifications contain detailed information about the screening
pathway.
• The clinical professional groups for colposcopy and laboratories have
met and reviewed current standards in the programme and a draft will be
submitted to the PHE Data group.
• Anticipated completed by end 2017
17. ResearchAdvisory Committee
17
The Research Advisory Committee roles are to:
• support and advise the programmes
• ensure applications do not adversely affect the uptake, acceptability and delivery of
the NHS Screening Programmes.
• review the scientific merit and feasibility of applications, and requests for data, and
their impact on the screening programme.
• determine which applications will have access to persons invited as part of the NHS
Screening Programme.
• produce recommendations for action following consideration of applications
• assess possible areas of duplication, and to provide liaison between research groups
considering similar projects
• receive regular updates and final project reports from all applications
• maintain a database of all applications
• ensure, when required PHE ODR approvals process is followed.
Research – new groups to drive change
18. For PHE Screening Programmes:
The research co-ordinator will be the first point of contact for screening
applications and will assist investigators throughout the application
process.
Data managers may work with applicants, when required to agree proposed
data specifications
The relevant Research Advisory Committees (RAC) will need to approve the
request to access data before the application can progress through the
relevant approvals i.e. PHE ODR
For applications that do require PHE ODR approval the RAC outcome letter will
include feedback from the ODR validation exercise
ODR will assign the research co-ordinator as the ‘account manager’ for the
project.
18 Presentation title - edit in Header and Footer
19. Updated Programme Guidance
• Guidance for the training of cervical sample
takers December 2016
• Approved HPV tests for HPV triage and test of
cure January 2017
• Laboratory quality control and assurance for
human papillomavirus testing January 2017
• Sample Acceptance guidance for laboratories
Published April 2017
• Call and recall guidance Published April 2017
• EQA Protocol changes April 2017
19 Cervical Screening Programme Update 12 10 2017 E-learning Launch
20. Guidance soon to be published
In progress:
• Ceasing guidance
• Failsafe guidance
• HBPC role changed title CSPL
• Review of Cervical Screening Invasive audit
• Achievable Benchmarks in Cytopathology
• Histology guidance
• HPV Primary Screening Implementation guide
• Colposcopy and programme management gudiance
• Programme standards.
20 Cervical Screening Programme Update 12 10 2017 E-learning Launch
21. Primary Care Support England PCSE
supports the National Cervical Screening
Programme by:
• Providing Prior Notification Lists (PNLs) of patients due for
screening to GP practices
• Sending out call and recall letters to patients eligible for
cervical screening tests
• Notifying patients of test results once we receive these
from laboratories
• Receiving and updating discharge lists from colposcopy
clinics
• Updating patient records with results
21
22. What will be different?
• PCSE are not changing what they do, just improving the
service by using more modern technology.
• Most noticeably, replacing NHAIS (Exeter system) with a
single database accessed via PCSE Online
• The information required for the different screening tasks
you undertake won’t change but the look and feel of the
new system will be easier to navigate and intuitive to use.
22
23. Benefits:
• One screen to access all screening information & histories
(according to user access permissions)
• Ability to download a prepopulated HMR101 form
• Opportunity to update screening records at any point during the
screening cycle, not just at PNL & FNR time
• Greater flexibility to manage ceasing, deferring and delaying
notifications
• The ability to save PNLs and amend them after submission to
PCSE
• Ability to upload ceasing and deferral forms online, reducing print &
postage costs
• A more timely, secure & traceable process to update screening
records
23
24. Benefits:
• Improved Colposcopy Discharge Report process - currently 100%
manual; transformed service will allow direct data upload from
Colposcopy to PCSE
• More timely lab file receipt reports and exception reports for
laboratories
• More timely access to women’s screening histories if they relocate
to a new practice within England
• Improved result matching processes should reduce the number of
mismatches so result letters can be issued more quickly
• Integrated Sexual Health Services (CASH/GUM clinics) will have
the facility to view screening records of women attending their
clinics.
24
25. When?
• The plan is to introduce these improvements in Summer 2018
What do you need to do?
PCSE will be sending out further information over the coming months including:
• The IT specification required to access PCSE Online
• How to register to use the new service
• Online user guidance
Updates will be distributed via Hospital Based Programme Coordinators and
Screening & Immunisation contacts in area teams.
You can also access latest news and bulletins on the PCSE website
www.pcse.england.nhs.uk
If you have any queries about the cervical screening transformation programme
please contact: karen.burgess@nhs.net
25
26. Cervical Screening SpotlightActions
• Present Data in more accessible way
• Influences of activity via GP contract
• Agree national language of targets
• Flag additional needs in call and recall
services
Action to
Improve
coverage
• Increase range of providers who can
provide screening
• Increase community engagement, who is
best to do what, how are messages
communicated, evaluate and share best
practice
• Work with CASH and GUM services
Commissioner,
provider local
action to improve
coverage
Cervical Screening Programme Update 12 10 2017 E-learning LaunchCervical Screening Programme Update 12 10 2017 E-learning Launch
28. Primary Care Data Pack
• Collaborative piece of work with PHE, Jo’s Trust, NHS
Digital
• Provide meaningful Coverage data at CCG, L.A and
practice level
• https://www.gov.uk/government/publications/cervical-
screening-coverage-and-data
28 Cervical Screening Programme Update 12 10 2017 E-learning Launch
31. To summarise
• The cervical screening programme continues to evolve
and adapt according to the evidence.
• The current changes are significant however working
together will support the programme in achieving the
aim:
31 Cervical Screening Programme Update 12 10 2017 E-learning Launch
32.
33. Producing the cervical screening
e-learning
Jonathan Waldheim, Digital Project Manager, Screening, Public
Health England
35. Background
2008: Collaborative development between North East and Yorkshire and
Humber.
2012: Initial discussions to update using regional developers.
2014: Further updates and complete overhaul the content for the NEYH region
using regional developers and talent.
35 Cervical Sample Taker Training
36. Making the resource national
2016: Agreed that this would become a national resource rather than just a
regional resource
2017: extensive peer review and feedback on the resource. Technical testing
with the e-LfH team where the resource will be accessed.
36 Cervical Sample Taker Training
37. e-Learning for Healthcare (e-LfH)
37 Cervical Sample Taker Training
• NHS approved platform for hosting e-
learning
• Resources available for anyone working
in or delivering services for the NHS
• Content exists alongside all existing e-
learning for the national screening
programmes
60. Discussion and panel Q&A
DeclanO’Brien, NationalEducationManager,Screening,PublicHealthEngland
RuthStubbs,NationalProgrammeManagerCervicalScreening,PublicHealthEngland
CatherineWitney,NationalEducationandTrainingManager,Screening,PublicHealth
England
JonathanWaldheim,DigitalProjectManager,Screening,PublicHealthEngland
LouiseGardham,TechnologyEnhancedLearningDeveloperHealthEducationEngland
61.
62. Future education programme
developments
Catherine Witney, National Education and Training Manager,
Screening, Public Health England
Ruth Stubbs, National Programme Manager, Cervical Screening,
Public Health England
65. Cervical Screening Education and Training
Cervical Screening Education and Training CSET
What is the groups remit?
The education and training pathway for :
• staff taking cervical samples
• staff signing out negative and inadequate cervical cytology reports
The group can recommend training initiatives for staff who sign out abnormal
cervical cytopathology reports
Training for virology or colposcopy is not included
65 Future cervical screening programme education developments
66. Cervical Screening Education and Training
Who is involved?
Membership of the group is drawn from:
PHE screening
Education Manager Cancer Screening Programmes (Chair)
National Lead for Stakeholder Information and Professional Education and Training
National Cervical Screening Programme Manager (Deputy Chair)
Screening QA Service (SQAS) Portfolio Lead Education & Training
Cytology Education Manager / Secretariat
Representatives from professional organisations
British Association for Cytopathology (BAC)
Institute of Biomedical Science (IBMS)
Royal College of General Practitioners (RCGP)
Royal College of Pathologists (RCPath)
Royal College of Nursing (RCN)
Director of UK Cytology Training Centres
Cancer Screening & Learning Disabilities Network
66 Future cervical screening programme education developments
67. Cervical Screening Education and Training
How does the group work
CSET group meets every 6 months
CSET has core working groups
• Sample Taker sub-committee cervical sampling
• Examination sub-committee cervical cytology screening
• Assessments sub-committee training provision and delivery
Task & finish groups
Examples of work undertaken
• review group for the sample taker update eLearning resource
• submission of CTC initial sample taker courses for RCN approval
67 Future cervical screening programme education developments
68. Sample taker training approval/endorsement
Cervical Sample Taker Initial Training (2-day theory course) RCN accredited
Delivered by 4 Cytology Training Centres in England:
Birmingham Cytology Training Centre
London Regional Cytology Training Centre
North of England Pathology Screening Education Centre
South West Regional Cytology Training Centre
Course participants are awarded 12 CPD hours upon completion and receive a
certificate from the RCN
68 Future cervical screening programme education developments
69. Sample taker training approval/endorsement
NHS Cervical Screening Programme Guidance for the training of cervical
sample takers
Independent training providers should ensure their training provision is
endorsed and regulated by an appropriate professional body. An appropriately
regulated higher education provider (or similar professional body) should
deliver training in screening theory. Training should be quality assured. The
training institution should be able to demonstrate the ability to meet the
competencies set out in this guidance.
69 Future cervical screening programme education developments
70. Sample taker training approval/endorsement
How the Cytology Training Centres met the requirement
The RCN endorsement and accreditation service includes a rigorous peer
review process to validate the educational outcomes of the training programme
Training being quality assured, applies to the framework in which training is
delivered
• CTC are quality assured through existing arrangements with their:
• employing Trusts
• local SQAS teams
• commissioners for the provision of sample taker training
70 Future cervical screening programme education developments
71. HPV Primary screening implementation
Training to support HPV Primary screening implementation
Training packages are being developed to support the workforce as part of the
national implementation of primary HR-HPV testing with cytology triage
Staff groups include :
• sample takers in primary care and colposcopy units
• laboratory staff cervical screener ,BMS,Consultant BMS
• colposcopists
• cervical screening provider lead CSPL formerly HBPC
71 Future cervical screening programme education developments
72. HPV Primary screening implementation
HPV primary screening: training for sample takers
The ELearning module will support sample takers in primary care and
colposcopy clinics to answer women’s questions about HPV primary screening
The module will include:
• HPV and cervical screening
• transmission of HR-HPV
• pilot of primary HR-HPV testing
• Primary HR-HPV testing algorithms
• possible results
• sample taker training/monitoring
• assessment and completion certificate
Will be hosted on HEE eLearning for health website
Sample takers are expected to complete the module prior to implementation and roll out
72 Future cervical screening programme education developments
73. HPV Primary screening implementation
HPV primary screening: training for colposcopists
A national colposcopy e-learning module is being developed by PHE and the British
Society for Colposcopy and Cervical Pathology BSCCP
It will provide colposcopists with confidence to follow the primary HPV testing
pathway and discharge women appropriately
To include:
• why we are moving to primary HPV testing
• effects of new pathways on referrals
• colposcopy management algorithm
• scenarios to support the colposcopist `s follow the pathway
• future developments
• certificate of completion
Will be hosted on HEE eLearning for health website linked from BCSSP website
Completing the resource is not compulsory, but considered good practice prior to implementation
73 Future cervical screening programme education developments
74. HPV Primary screening implementation
HPV primary screening: training for laboratory staff
All staff involved in the screening and reporting of cytology samples following
primary HR-HPV testing need an up-to-date knowledge of the HPV screening
pathway
CSET will develop training content to include:
• results of randomised controlled trials and pilots of primary HR-HPV testing
• primary HR-HPV screening protocols and management algorithms
• HR-HPV test and cytology workflow through the laboratory
• quality assurance
Training will be delivered by Cytology Training Centres
74 Future cervical screening programme education developments
75. HPV Primary screening implementation
HPV primary screening training: Cervical screening provider lead CSPL
Laboratory service reconfigurations resulting in large screening laboratories
will require extra coordination with :
• women being referred to multiple colposcopy units
• audit of invasive cancers across separate trusts
The role of the CSPL must ensure links are maintained between all elements of
the local programme
How will the CSPL role be supported?
NHSCSP guidance for the role of the CSPL
Training requirements will be developed based on NHSCSP guidance
75 Future cervical screening programme education developments
76. Trainee GP sample taker training provision
GP trainee sample taker training provision
Potential problems :
• courses historically difficult to access
• difficulty for trainees to obtain necessary supervised experience
• difficulties for established GPs to keep up-to-date
A regional training model which allowed ST2 trainees to access training in
higher numbers is to be evaluated and if appropriate could be considered for
adopted as national guidance
76 Future cervical screening programme education developments
77. RCGP Cervical screening e-learning
How can we better engage with Primary Care practitioners?
NHS Screening programmes have experienced challenges in accessing GPs,
and primary care practitioners to provide programme information and updates.
RCGPs recommends the most effective option is:
• using short focussed e-learning
• modules 15 minutes to complete for maximum impact
NIPE e-learning feedback from Dirk Pilat, GP & RCGP medical director for e-learning:
“This is an area of learning that would really appeal to GPs, an area where currently have very little
content – I’d therefore imagine demand would be high’’
77 Future cervical screening programme education developments
78. RCGP Cervical screening e-learning
PHE screening and RCGP will collaborate to create ELearning resources to
meet the needs of GP and primary care covering:
key information about the conditions screened for
screening pathways
primary care practitioner role in informing and supporting their patients
Pilot phase
Initially modules are being developed and piloted for:
• Cervical screening
• Diabetic Eye Screening
• Sickle cell and Thalassaemia screening
Development will start early 2018 with products available mid 2018
78 Future cervical screening programme education developments
80. Cervical screening coverage
data project
RuthStubbs
NationalCervicalScreeningProgrammeManager
Public Health England leads the NHS Screening Programmes
81. Cervical screening coverage
data project
RuthStubbs
NationalCervicalScreeningProgrammeManager
Public Health England leads the NHS Screening Programmes
82. Background
• cervical screening coverage is falling – high profile to address this for NHS
England and PHE
• stakeholder feedback - data not easily available or timely
• multiple definitions complicates the situation
• agreement to set up small group to look at this
82 Cervical screening coverage data project
83. Projectobjectives
• to make available more timely coverage data to internal and external
stakeholders
• to develop a primary care level data pack that supports and empowers GP
practices and CCGs to improve cervical screening attendance and
coverage rates
• pragmatic decision on what to include – avoiding lengthy delays developing
new things
• “one-stop shop” for people to go to
83 Cervical screening coverage data project
84. How we will buildon this?
• developing cervix data availability
• improved timeliness
• additional data planned
• evaluation of use of tools
• applying same methodology to breast and bowel data
• breast project group just initiated
• paper on project discussed at health inequalities strategic oversight board
• aim to include use of data in new health inequalities standards
• being included in new e-learning for sample takers being developed by the
Programme (launch planned for the Autumn)
84 Cervical screening coverage data project
86. Choose CCG from dropdown = =
>
NHS North Cumbria CCG
NHS England North
(Cumbria And North East)
Report
covers
period up
to 30th
Septembe
r 2016
For 25 to 49 age group - Standard: 80% of women to have adequate screening
test within previous 3.5 years
For 50 to 64 age group - Standard: 80% of women to have adequate screening test
within previous 5.5 years
NHS North
Cumbria CCG
No. of
eligible
women
on last
day of
review
period
No. of
women
screene
d in
previou
s 3.5
years
3.5-year
coverage
%
NHS Cumbria
CCG
No. of
eligible
women
on last
day of
review
period
No. of
women
screene
d in
previou
s 5.5
years
5.5-year
coverage
%
Screen
s
neede
d to
meet
80%
RANK of 209
CCGs
Screen
s
neede
d to
meet
80%
RANK of 209
CCGs
Performance of
CCG 75,556 56,841 75.23 3,604
24
Performance of
CCG 49,787 39,212 78.76 618
52
Performance
for the
practices that
make up the
CCG
No. of
eligible
women
on last
day of
review
period
No. of
women
screene
d in
previou
s 3.5
years
3.5-year
coverage
%
RANK
Previous
performa
nce
(August
2015)
Performance for
the practices
that make up the
CCG
No. of
eligible
women
on last
day of
review
period
No. of
women
screene
d in
previou
s 5.5
years
5.5-year
coverage
%
RANK
Previous
performa
nce
(August
2015)
Screen
s
neede
d to
meet
80%
of 76
practic
es in
CCG
of
practic
es
(nation
al)
Screen
s
neede
d to
meet
80%
of 76
practic
es in
CCG
of
practic
es
(nation
al)
Surger
y 1
(
A1234
5
)
1,435 1,177 82.02 n/a 1 262 82.48
Surgery
8
(
H820
67
)
369 331 89.70 n/a 1 85 89.37
Surger
y 3
(
A1234
6
)
776 633 81.57 n/a 2 324 79.17
Surgery
1
(
H820
70
)
1,208 1,036 85.76 n/a 2 314 84.10
Surger
y 6
(
A1234
7
)
802 652 81.30 n/a 3 368 83.03
Surgery
3
(
H820
34
)
1,890 1,564 82.75 n/a 3 1,072 84.57
Surger
y 5
(
A1234
8
)
1,587 1,285 80.97 n/a 4 417 81.11
Surgery
4
(
H820
31
)
591 482 81.56 n/a 4 1,575 82.05
Surger
y 8
(
A1234
9
)
<under
6>
<under
6> -2.00
* * *
*
Surgery
6
(
H820
83
)
947 771 81.41 n/a 5 1,641 81.68
Source for cervical coverage
data:
National Health Application and Infrastructure Services (NHAIS) systems accessed using Open
Exeter. (https://nww.openexeter.nhs.uk/nhsia )
86 Cervical screening coverage data project
User selects one
of the 209 CCGs
The report has two tables. One for women aged 25 to 49, one for women aged 50
to 64
NB each table is ordered by descending
performance for the particular age
group.
This column ranks the
performance of the CCG
and individual practices
Performance
for the
practice from
12 months
ago
Small number (values 5 or below)
suppression is used to mitigate
potential identification of
individuals.
Where only one value has been
suppressed within a region, the
next smallest value is also
suppressed.
PHE Coveragetables– key for tables
87. 87 Cervical screening coverage data project
Choose CCG from dropdown = = > NHS Rushcliffe CCG
NHS England Midlands And East (North
Midlands)
Report covers period up to
31st December 2016
For 25 to 49 age group - Standard: 80% of women to have adequate screening test
within previous 3.5 years
For 50 to 64 age group - Standard: 80% of women to have adequate screening test
within previous 5.5 years
NHS Rushcliffe CCG
No. of
eligible
women
on last
day of
review
period
No. of
women
screene
d in
previou
s 3.5
years
3.5-
year
cover
age %
NHS Rushcliffe CCG
No. of
eligible
women
on last
day of
review
period
No. of
wome
n
screen
ed in
previo
us 5.5
years
5.5-
year
cover
age %
Screen
s
neede
d to
meet
80%
RANK of 209
CCGs
Screen
s
neede
d to
meet
80%
RANK of 209
CCGs
Performance of CCG
19,993 16,223
81.14 n/a 1 Performance of CCG
11,454 9,686
84.56 n/a 1
Performance for the 13 practices that
make up the CCG
No. of
eligible
women
on last
day of
review
period
No. of
women
screene
d in
previou
s 3.5
years
3.5-
year
cover
age %
RANK
Previou
s
perform
ance
(August
2015)
Performance for the 13 practices
that make up the CCG
No. of
eligible
women
on last
day of
review
period
No. of
wome
n
screen
ed in
previo
us 5.5
years
5.5-
year
cover
age %
RANK
Previous
performa
nce
(August
2015)
Screen
s
neede
d to
meet
80%
of 13
practic
es in
CCG
of 7751
practic
es
(nation
al)
Screen
s
neede
d to
meet
80%
of 13
practic
es in
CCG
of
7751
practic
es
(natio
nal)
RADCLIFFE ON TRENT
HEALTH CENTRE
(C84084)
1,167 1,002 85.86
n/a
1 24 85.87 DR L H K KANDOLA
(
C8470
3
)
441 394 89.34
n/a
1 50 89.30
DR L H K KANDOLA
(C84703)
1,019 863 84.69
n/a
2 43 85.14 DR SCAFFARDI & PTRS
(
C8402
5
)
742 659 88.81
n/a
2 65 87.76
DR KELLY PTRS
(C84005)
1,979 1,666 84.18
n/a
3 53 84.44
MUSTERS MEDICAL
PRACTICE
(
C8409
0
)
1,002 882 88.02
n/a
3 91 88.25
RUDDINGTON MEDICAL
CENTRE
(C84028)
1,170 978 83.59
n/a
4 71 81.77 DR KELLY PTRS
(
C8400
5
)
1,185 1,041 87.85
n/a
4 98 87.83
DR JELPKE & PTRS
(C84086)
1,975 1,643 83.19
n/a
5 89 83.25
RADCLIFFE ON TRENT
HEALTH CENTRE
(
C8408
4
)
767 670 87.35
n/a
5 117 87.58
MUSTERS MEDICAL
PRACTICE
(C84090)
1,547 1,259 81.38
n/a
6 245 80.53 DR JELPKE & PTRS
(
C8408
6
)
798 679 85.09
n/a
6 313 85.40
DR LANGRIDGE & PTRS
(C84048)
1,413 1,131 80.04
n/a
7 468 81.66
RUDDINGTON MEDICAL
CENTRE
(
C8402
8
)
583 491 84.22
n/a
7 482 81.80
BELVOIR HEALTH GROUP
(C84017)
3,790 3,012 79.47 20 8 592 79.03
CASTLE HEALTHCARE
PRACTICE
(
C8460
5
)
1,596 1,343 84.15
n/a
8 495 84.43
WEST BRIDGFORD MEDICAL
CENTRE
(C84621)
986 780 79.11 9 9 671 79.08 DR LANGRIDGE & PTRS
(
C8404
8
)
1,106 916 82.82
n/a
9 849 83.26
CASTLE HEALTHCARE
PRACTICE
(C84605)
2,880 2,242 77.85 62 10 1,051 77.53 DR FOSTER & PTRS
(
C8204
0
)
693 568 81.96
n/a
10 1,171 83.41
DR FOSTER & PTRS
(C82040)
1,144 852 74.48 64 11 2,365 72.84 BELVOIR HEALTH GROUP
(
C8401
7
)
2,314 1,858 80.29
n/a
11 1,963 81.43
DR SCAFFARDI & PTRS
(C84025) <Suppre
ssed>
<Suppres
sed> -1.75
* * *
85.70
WEST BRIDGFORD
MEDICAL CENTRE
(
C8462
1
) <Suppress
ed>
<Suppr
essed> -1.75
* * *
81.90
This sheet lists all practices in the CCG area and
ranks them by cervical coverage performance.
PHE Coveragetables– Example
88. 88 Cervical screening coverage data project
Choose CCG from dropdown = = > NHS Coventry And Rugby CCG
NHS England Midlands And East
(West Midlands)
This CCG
has
75 practices
Report covers
period up to 31st
December 2016
Age Range
25 to 49
Standard:
80% with an
adequate
test in last
3.5 years
CCG
Performance
67.62 %
Rank of 209
CCGs
160
Age Range
50 to 64
Standard:
80% with an
adequate
test in last
5.5 years
CCG
Performance
78.18 %
Rank of 209
CCGs
78
0
200
400
600
800
1000
1200
1400
1600Age range: 50 to 64
95.69
93.10
87.83
87.24
86.20
86.19
85.06
84.95
84.68
84.30
82.67
82.55
82.29
82.25
81.65
81.59
80.90
80.89
80.65
80.60
80.51
79.96
79.90
79.72
79.69
79.10
78.99
78.98
78.65
78.57
78.55
78.49
78.45
78.42
78.24
77.90
77.80
77.51
77.33
77.17
76.69
76.38
76.28
76.11
75.67
75.54
75.45
75.43
75.20
75.10
74.92
74.53
74.11
73.96
73.91
73.61
73.52
73.38
73.00
72.57
72.17
72.14
72.12
71.68
71.43
71.37
70.31
69.28
67.75
65.08
65.05
63.08
37.50
0
20
40
60
80
100
Y04952
M86014
M86026
M84004
M86034
M84020
M86638
Y04947
Y00140
M86038
M84023
M86046
M86610
M86035
M86032
M86015
M86037
M86027
M86624
M86006
Y04949
M86607
M86020
M86617
M86045
M86008
M86048
M86002
M86613
M84065
M86004
M86013
M86012
M86041
Y04965
M86029
Y00060
Y02613
80% or higher 75% to 79.99% 70% to 74.99% below 70%
0
1000
2000
3000
4000
5000Age range: 25 to 4980.15
80.12
78.15
77.99
77.15
76.25
76.17
75.93
75.87
75.09
74.73
74.69
74.36
73.34
72.95
72.87
72.78
72.65
71.68
71.68
70.93
70.88
70.82
70.80
70.68
70.46
70.22
69.85
69.60
69.50
69.36
69.17
68.88
68.85
68.67
68.67
68.64
67.29
67.21
67.10
66.70
66.12
65.70
65.35
65.21
64.66
64.60
64.60
64.48
63.42
63.19
62.71
62.46
62.14
61.70
60.60
60.00
59.91
59.76
59.33
59.21
58.98
58.20
57.94
57.72
57.63
57.23
57.14
55.57
53.71
52.84
50.65
48.75
0
20
40
60
80
100 Y04952
M86014
M86026
M84004
M86034
M84020
M86638
Y04947
Y00140
M86038
M84023
M86046
M86610
M86035
M86032
M86015
M86037
M86027
M86624
M86006
Y04949
M86607
M86020
M86617
M86045
M86008
M86048
M86002
M86613
M84065
M86004
M86013
M86012
M86041
Y04965
M86029
Y00060
Y02613
80% or higher 75% to 79.99% 70% to 74.99% Below 70%
This sheet shows CCG
performance on two graphs. One
for 25 to 49s, the lower for 50 to
64s
Key
Every
practice
from the
selected
CCG is
shown .
Symbol
colour
denotes
whether
performan
ce meets
80%
standard
(dark
green), is
over 75%
(light
green),
between
70% &
75%
(blue),
under 70%
(orange)
Grey bars
show
relative
size of
eligible
population
for each
practice
PHE Coveragegraphs - Example
89. Thanksand acknowledgments
• Core Group
• Philippa Pearmain (chair)
• Ruth Stubbs
• Rad Latinovic
• Simon Wrathall
• Project group stakeholders
• Rob Music and Kate Sanger, Jo’s Cervical Cancer Trust
• Nicola Benge and Dan Seddon, SILs
• Anthony Cunliffe, Macmillan
• Ginny Fieldsend, Kathie Binysh and Nikki Osborne, NHS England
• John Wisset, Capita
• Ben Pace, David Connolly, Pritpal Ryat, NHS Digital
• IEPP
• TJ Day, Jonny Waldheim, Mike Harris, IEPP
89 Cervical screening coverage data project
92. Cervical Screening Coverage
Data resource
Pritpal Rayat,Analytical Section Head of Screening and
Immunisations, NHS Digital
Ben Pace, NHS Digital Senior InformationAnalyst, Screening and
Immunisations, NHS Digita
93. Cervical Screening eLearning event
Cervical Screening Coverage Data Resource
presented by Pritpal Rayat & Ben Pace,
Screening & Immunisations Team
94. Overview
• NHS Digital – who we are?
• The role of NHS Digital
• Data and Information Strategy
• Cervical Screening Coverage Data Project
• Cervical Screening Interactive Data Dashboard
• Live Demo
• Q & A
94
95. NHS Digital – who we are?
• Formerly known as ‘The Health and Social Care Information Centre’ (HSCIC)
• We are the national information and technology partner for the health and care system
• Our vision is to harness the power of information and technology to make health and
care better
• We aim to:
– ensure that every citizen’s data is protected
– establish shared architecture and standards so everyone benefits
– implement national services to meet national and local needs
– support care organisations to get the best out of technology, data and information
– enable much better use of health and care information
• We have a statutory duty to help the health and care system drive greater value from
the data and information it generates
95
96. The role of NHS Digital
96Fig. 1. The health and care system that NHS Digital supports
Health and care professionals
Researchers
ALBs
Politicians
Citizens
Media
rities
Health and care providers
Living healthy lives and
making choices about
health
Providing health and
care services
Organising the delivery of
health and care services
Overseeing, influencing
and regulating the delivery
of health and care services
Information and technology
delivery partner for the
health and care system
DH
Health and care professionals
Health and care providers
ALBs Regulators
Commissioners
Charities
DH
Media Politicians
Researchers
97. Data and Information Strategy
• It sets out the future role that NHS Digital will take in driving forward the use of data and
information in delivering the Five Year Forward View and government priorities
• It also aligns to the shared vision and plans for data and information across the health and
care system that are owned by the National Information Board and the Paperless 2020
programme
• Some of the key themes towards achieving this Strategy include:
• Engaging with our customers proactively to understand their requirements
• Being the single authoritative source of data across the health and social care system
• Utilising data to add value in all that we do and making data accessible to our customers in a timely way
• Presenting and publishing data and statistics in innovative ways that add value for our customers
97
98. Cervical Screening Coverage Data Project
• PHE led project working collaboratively with NHS Digital and Jo’s Cervical Cancer Trust
• Cervical Screening coverage has continued to fall year on year – key area for improvement and is a
high level PHE objective
• NHS Digital publish coverage data annually as part of the Cervical Screening Programme Statistics
bulletin
• Increased requirement for more timely coverage data to be made available in the public domain at
more granular levels (i.e. GP Practice/CCG)
• This has led to the development of a set of data resources that will help support and empower GP
practices and CCGs to improve cervical screening attendance and coverage rates
• NHS Digital have developed a web based interactive dashboard and first release went live in June
2016, with updates published on a quarterly basis
• Data on attendance and coverage rates published as ‘management information’ down to GP
Practice level
98
99. Cervical Screening Interactive Data Dashboard
• Developed in a software called Microsoft Power BI and is accessible via the internet
• Focus on making data available ‘interactively’ through many types of visualisation, including graphs, charts
and maps, and other dynamic features
The Dashboard:
• Presents data for screening coverage at two groups – 25-49 years and 50-64 years at GP Practice, CCG and
Local Authority levels which is released into the public domain every three months
• Includes data for the number of women eligible and screened
• Provides information on how GP Practices rank within the CCG and Nationally in relation to cervical
screening coverage rates
• Data are obtained monthly reports from the Open Exeter system, which is hosted by NHS Digital
• Provides end users with a more immediate source for local oversight and commissioning of cervical
screening services
• Helps those involved in managing the screening programme make better informed decisions on the most up
to date data available
99
100. Live Demo
• http://bit.ly/cervical_screen_coverage_quarterly_GPdata
• http://bit.ly/cervical_screen_coverage_quarterly_CCGdata
• http://bit.ly/cervical_screen_coverage_quarterly_LAdata
Relevant/Related Sources:
NHS Digital - http://http//digital.nhs.uk/pubs/cervical_screen_coverage_quarterly
PHE - https://www.gov.uk/government/publications/cervical-screening-coverage-and-data
Jo’s Cervical Cancer Trust - https://www.jostrust.org.uk/information-healthcare-
professionals/information-practice-nurses-and-gps
100
